These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9293409)

  • 1. Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer.
    Kitamura M; Shimizu M; Kita Y; Yoshio H; Ino H; Misawa K; Matsuyama T; Mabuchi H
    Jpn Circ J; 1997 Sep; 61(9):781-6. PubMed ID: 9293409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.
    Carasso S; Rakowski H
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1306-8. PubMed ID: 19041573
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial fibrosis assessment by semiquantitative, point-counting and computer-based methods in patients with heart muscle disease: a comparative study.
    Vasiljević JD; Popović ZB; Otasević P; Popović ZV; Vidaković R; Mirić M; Nesković AN
    Histopathology; 2001 Apr; 38(4):338-43. PubMed ID: 11318899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM; Haugaa KH; Strøm EH; Scott H; Dahl CP; Leren TP; Geiran OR; Endresen K; Edvardsen T; Aakhus S; Amlie JP
    Europace; 2013 Sep; 15(9):1319-27. PubMed ID: 23426552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.
    Wilson JM; Villareal RP; Hariharan R; Massumi A; Muthupillai R; Flamm SD
    Tex Heart Inst J; 2002; 29(3):176-80. PubMed ID: 12224720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Values of Apelin for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Zhou Y; Yuan J; Wang Y; Qiao S
    Int Heart J; 2019 May; 60(3):648-655. PubMed ID: 31019180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive quantitation of myocardial fibrosis using combined tissue harmonic imaging and integrated backscatter analysis in dilated cardiomyopathy.
    Mizuno R; Fujimoto S; Saito Y; Nakamura S
    Cardiology; 2007; 108(1):11-7. PubMed ID: 16960443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.
    Iles LM; Ellims AH; Llewellyn H; Hare JL; Kaye DM; McLean CA; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):14-22. PubMed ID: 25354866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual association of endomyocardial fibrosis and hypertrophic cardiomyopathy in a patient with heart failure.
    Salemi VM; D'andretta Iglezias S; Benvenuti LA; Filho JC; Rochitte CE; Shiozaki AA; Mady C
    Cardiovasc Pathol; 2012; 21(2):e23-5. PubMed ID: 21641824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy.
    Saito M; Okayama H; Yoshii T; Higashi H; Morioka H; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Hamada M; Higaki J
    Eur Heart J Cardiovasc Imaging; 2012 Jul; 13(7):617-23. PubMed ID: 22271116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial remodeling and pathologic hypertrophy.
    Weber KT; Brilla CG; Janicki JS
    Hosp Pract (Off Ed); 1991 Apr; 26(4):73-80. PubMed ID: 2010482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis is associated with biventricular dysfunction in patients with hypertrophic cardiomyopathy.
    Prinz C; van Buuren F; Faber L; Bitter T; Bogunovic N; Burchert W; Horstkotte D
    Echocardiography; 2012 Apr; 29(4):438-44. PubMed ID: 22150531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of myocardial fibrosis and its relation to function in essential hypertension and hypertrophic cardiomyopathy.
    Sugihara N; Genda A; Shimizu M; Suematu T; Kita Y; Horita Y; Takeda R
    Clin Cardiol; 1988 Nov; 11(11):771-8. PubMed ID: 3233804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative analysis of myocardial fibrosis in myocardial biopsies--a comparison between computer analysis and point counting method].
    Yamamoto K; Adachi K; Sakanashi T; Nozuhara A; Mayumi F; Sako S; Fujiura Y; Okamoto T; Tanaka H; Toshima H
    Kokyu To Junkan; 1991 Jul; 39(7):691-6. PubMed ID: 1896663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in cardiovascular medicine. Progressive myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by cardiovascular magnetic resonance.
    Gebker R; Neuss M; Paetsch I; Nagel E
    Circulation; 2006 Aug; 114(5):e75-6. PubMed ID: 16880332
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
    Sueyoshi E; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial ultrasonic tissue characterization for estimating histological abnormalities in hypertrophic cardiomyopathy: comparison with endomyocardial biopsy findings.
    Mizuno R; Fujimoto S; Yamaji K; Yutani C; Hashimoto T; Nakamura S
    Cardiology; 2001; 96(1):16-23. PubMed ID: 11701936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.